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The possibility of fibronectin production by C6 glioma cells was examined with 
assays which require protein synthesis. Proteins produced by C6 cells using ra- 
diolabeled amino acid precursors were tested for affinity to collagen by binding 
to immobilized gelatin. The predominant collagen binding protein made by C6 co- 
electrophoresed with fibronectin synthesized by control fibroblasts and with the 
larger of the two proteins in unlabeled fibronectin when applied to polyacrylamide 
gels with sodium dodecyl sulfate (SDS). In addition, C6 produced a larger collagen 
binding protein of approximately 270,000 molecular weight. Solubilities in urea 
solutions of the collagen-binding proteins made by C6 cells and fibroblasts were 
similar. Immunofluorescence showed fibronectin associated with the C6 cell mon- 
olayer, but less abundant than the fibronectin associated with fibroblasts. Results 
provide evidence for the production of fibronectin by the C6 glioma cell line. 
INTRODUCTION 
Fibronectin is an adhesive protein composed of two chains of 220,000- 
240,000 daltons covalently linked by disulfide bonds. Fibronectin is im- 
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plicated in a wide variety of cellular interactions, including cell-cell adhe- 
sion, cell adhesion to substrata and cell spreading. Fibronectin exists in 
conditioned media, intracellularly and as an aggregate on the surface of 
cultured fibroblasts, endothelial cells and certain human gliomas and in 
circulating blood (1-5). Ceils release fibronectin when exposed to IM 
urea. 8M urea more completely solubilizes fibronectin. Fibronectins from 
all sources share the functional characteristic of binding to collagen. 
Since fibronectin in vivo is more commonly associated with endothe- 
lium, mesenchyme and serum than with glial and glioma cells (4, 6-10), 
it was of interest to determine whether a glioma cell line established in 
vitro and recognized as glial actually produced fibronectin. This was dif- 
ficult to ascertain from previous studies for two reasons. Immunologic 
assays of fibronectin associated with cultured gliomas have not required 
synthesis of fibronectin by the glioma cells (1, 3, 8, 9). Without proof of 
synthesis, exogenous fibronectin cannot be rigorously excluded as a 
source of interference with these assays. This second reason involves the 
nature of cells cultured from gliomas. Many of these cells lack markers 
seen on glial and glioma cells in vivo such as glial fibrillary acid protein 
(GFAP) or S-100 protein (I, 3, 6, 10). 
The C6 glioma cell line was chosen for the present study because it is 
known to possess markers associated with glial differentiation including 
glial fibrillary acidic protein (11, 12), glutamine synthetase (13), CNP'ase 
(13), S-100 protein (14), and a cyclic AMP mediated [3-adrenergic receptor 
which triggers differentiation to multipolar, stellate cells (15). C6 is the 
first line certified as glial by the American Type Culture Collection 
(ATCC). Assays requiring synthesis of fibronectin by C6 were applied. 
Previous evidence for and against production of fibronectin by C6 cells 
has been reported (8, 9, 16). Additional evidence for the production of 
fibronectin by C6 cells is now presented. 
EXPERIMENTAL PROCEDURE 
Cells. Certified C6 rat glioma cells, originally cloned by Benda (17) from an N-nitroso- 
methyl-urea induced rat glioma, were obtained from the ATCC (Rockville, Maryland) at 
passage 36 and used during the next 10 passages. Culture medium consisted of Dulbecco's 
Modified Essential Medium (DMEM) containing 4.5 mg/ml glucose (GIBCO, Grand Island, 
New York) supplemented with 0.3 mg/ml glutamine, 10% fetal calf serum, 100 units/ml 
penicillin and 100 mcg/ml streptomycin (pen-strep). 
The standard source of cellular fibronectin, chick embryo fibroblasts (18), was used as 
controls. Chick embryos were obtained from Truslow Farms in Easton, Maryland and from 
Anne Harris and Betty Lovelace who also provided valuable assistance in their isolation 
and maintenance. Tertiary cultures of 10 day chick embryonic fibroblasts were prepared by 
described methods (19). 
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Cell monolayers were cultured in 100 c m  2 flasks (Becton Dickenson Co., Oxnard, Cali- 
fornia) to 100% confluency, a concentration of 2.5 x 105 fibroblast cells and of 4.5 x 105 
C6 cells per cm 2 of culture surface. They were maintained at 36~ in a humidified atmosphere 
of 7% CO2. After reaching 100% confluency, the cells were fed new medium. Two days 
later they were used for radiolabeling. 
Biosynthetic Radiolabeling. Confluent cell cultures were transferred to serum free medium 
containing DMEM, pen-strep and glutamine with 0.1 mCi/ml L-[~4C]leucine with specific 
activity of 340 mCi/mmol (New England Nuclear Corp. Boston, Massachusetts) substituted 
for unlabeled leucine, and incubated at 36~ for 22 hrs (18). Labeling conditions were chosen 
to simulate conditions established as satisfactory for characterization of fibronectin from 
fibroblasts (19). They included use of serum free medium to avoid possible influences of 
exogenous fibronectin and leucine. The medium was decanted and set aside for gelatin 
binding experiments. Duplicate flasks were incubated in the presence of 0.1 mg/ml cyclo- 
heximide which produced 98% inhibition of protein labeling as judged by precipitation with 
trichloracetic acid (20, 21). 
Collagen Binding. Radiolabeled collagen binding proteins for subsequent SDS polyac- 
rylamide gel electrophoresis were collected by previously described methods (22). Briefly, 
washed gelatin coupled to agarose beads (Pierce Chemical Co., Rockford, Illinois) was added 
to radiolabeled culture medium in 2 x volume sodium citrate buffer, pH 7.2 (2). After 20 
min, 4 x volume of citrate buffer was added and the solution stirred overnight at 4~ Beads 
were washed at 1600 rpm for 15 min (22). 
Polyacrylamide Gel Electrophoresis. Biosynthetically labeled collagen binding proteins 
were solubilized directly from beads by heating at 99~ for 1 min in 3% SDS, 5% 2-mer- 
captoethanol, 10% sucrose, and 0.002% phenol red to make a final volume of not more than 
100 txl (22-24). Solutions of more than 1 volume were lyophilized in silicouized glass tubes 
prior to electrophoresis. 
Polyacrylamide gel electrophoresis was in verticle slabs 120 mm in length. The 50-60 Ixl 
aliquots of sample were applied to slots in a 1.5 mm thick gel. The buffer system was Tris- 
glycine (23-25). Gels were run with spacers of 3% acrylamide, pH 6.7 and 5% acrylamide 
resolving gel, pH 8.2. Additional gels with a 4.5% resolving gel and no spacer were used. 
Electrophoresis was at constant current of 25 mA/gel at or below 200 volts until phenol red 
was within 0.5 cm of the end of the gel (3 to 5 hours). The gel was stained with Coomassie 
Brilliant Blue according to the procedure of Fairbanks (26). Molecular weight standards 
were simultaneously run with the proteins. Molecular weight standards included filamin 240 
K, myosin 200 K, beta-glucuronidase 130 K, and phosphorylase B 93 K (New England 
Nuclear Corp., Boston, Massachusetts) and chick cellular fibronectin 220 K (Bethesda Re- 
search Labs, Bethesda, Maryland). Plots of log molecular weight versus linear migration of 
protein were used to estimate molecular weights (23, 24). Gels were infiltrated with 2,5- 
diphenyloxazole, dried on filter paper, and exposed to Kodak XAR-5 X-ray film at -70~ 
Elution of Collagen Binding Proteins. To assess elution efficiency of high molarity urea 
and SDS solutions, gelatin-agarose beads with bound labeled proteins were suspended in 
10 x volume of either of 3 solutions and stirred overnight at 4~ 8 M urea in Tris-HCl, pH 
7.4 (4), 8 M urea, pH 11, or 10% SDS. Supernatant was centrifuged from beads and fractions 
of both were treated with Protosol, mixed with Econofluor and counted in an LKB 1216 
Rack Beta liquid scintillation counter as described (23). Counts were compared with counts 
directly extracted by Protosol from an equal portion of beads. 
Competition Binding to Collagen. Binding of 14C labeled extracellular proteins to gelatin- 
agarose beads was compared in the presence and absence of excess unlabeled fibronectin 
(Collaborative Research, Inc., Lexington, Massachusetts). Radiolabeled culture medium 
from C6 cells and fibroblasts (0.1 ml) were incubated with a 2 • volume of gelatin-agarose 
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beads which had been pretreated either with 100 tag fibronectin plus 400 ixg ovalbumin or 
with 500 Bxg ovalbumin. They were incubated overnight at 4~ in 3 ml sodium citrate buffer, 
pH 7.2, in 12 • 75 mm clear plastic tubes (Falcon 2054) with gentle agitation. Beads were 
washed three times in 10 x citrate buffer including an overnight and 8 hr wash at 4~ with 
gentle agitation. The cpm in the final wash could not be distinguished from background. 
Gelatin binding proteins were eluted from washed beads at 4~ overnight in 5 x volume of 
8 M urea at pH 11 with gentle agitation. One ml of all washes and elutions were counted 
in 10 x volume of RPI Safety Solve scintillant. 
Extraction of Proteins from Cellular Monolayers with Urea of Relatively Low Molarity. 
In order to test solubility in low molarity urea, radiolabeled cell monolayer cultures were 
rinsed four times with Hank's balanced salt solution (HBSS) (GIBCO). To the cell monolayer 
was added 25 ml of serum free DMEM with 2 mM phenylmethyl sulfonyl fluoride (PMSF). 
Culture flasks were incubated 1 hr at 36~ in a New Brunswick G24 Environmental Incubator 
shaker at 30 rpm. The solution was decanted and the monolayers rinsed once with PMSF- 
containing DMEM solution. The flasks were drained, and 20 ml of 1 M urea in DMEM/ 
PMSF solution was added. Flasks were incubated with shaking at 30 rpm for 2 hr at 36~ 
The procedure was repeated with 2 M urea solution. Following urea extraction, medium 
was centrifuged in a Sorvall RC-2B centrifuge at 4~ and 25,000 g for 15 min (19, 27, 28). 
Immunofluorescencefor Fibronectin. C6 and fibroblast cells were fed and grown in flasks 
and on sterile microscopic slides in 100 mm diameter culture dishes as described for the 
biosynthesis experiments except that fibronectin was removed from the fetal calf serum 
(FCS). This was done by passing the FCS through an affinity column of immobilized gelatin 
(Pierce Chemical Co., Rockford, Illinois) as described elsewhere (9). The treated FCS had 
no detectable fibronectin by turbidimetric assay (Boehringer-Mannheim, Mannheim, W: 
Germany), as compared with a fresh bovine plasma control which had 125 txg/ml fibr0nectin 
by this assay. 
After the cells reached 100% confluency, they were fed new medium without fibronectin. 
Two days later they were harvested with three washes of Hank's balanced salt solution 
followed by a 5 min. fixation in 100% methanol. After three rinses of 0.01 M phosphate 
buffered saline (PBS), pH 7.2 (Difco Labs., Detroit, Michigan), the cells were stained with 
fluoresceine conjugated rabbit anti-fibronectin (Cappel Labs., Div. Cooper Biomed., Mal- 
vern, Pennsylvania) diluted 1:100 in PBS (FITC Ranti-FN) for 15 rain. After three rinses 
in PBS, the cells were mounted in Gelvatol (Monsanto Chemical Co., Indian Orchard, Mas- 
sachusetts) and viewed with a Zeiss fluorescence microscope with epi-illumination. Control 
slides were stained as described using FITC R anti-FN absorbed with 200 ~tg of purified 
fibronectin (Collaborative Research, Inc., Lexington, Massachusetts). 
R E S U L T S  
A m o n g  v a r i o u s  l a r g e  p r o t e i n  m o l e c u l e s  b i o s y n t h e s i z e d  a n d  r e l e a s e d  b y  
C 6  g l i o m a  ce l l s  w a s  a p r e d o m i n a n t  p r o t e i n  w h i c h  b o u n d  c o l l a g e n  in  t h e  
r a n g e  o f  r e s o l u t i o n  o f  5 %  p o l y a c r y l a m i d e  ge l s .  T h i s  p r o t e i n  c o - e l e c t r o p -  
h o r e s e d  w i t h  t h e  m a j o r  p e a k  in  u n l a b e l e d  c e l l u l a r  f i b r o n e c t i n  s t a n d a r d  
( F i g u r e  1 p e a k s  a t  p o s i t i o n  l a b e l e d  1). D i f f e r e n c e s  in  o t h e r  p e a k s  b e t w e e n  
t h e  C 6  p r o t e i n s  w h i c h  b o u n d  c o l l a g e n  a n d  u n l a b e l e d  f i b r o n e c t i n  s t a n d a r d s  
w e r e  a l s o  a p p a r e n t .  
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Fro. t. Four and a half percent polyacrylamide slab gel electrophoresis in SDS of proteins 
reduced with 5% 2-mercaptoethanol (2-ME): (a) Autofluorogram of biosynthetically labeled 
extracellular proteins of C6 eluted from gelatin-agarose beads with 10% SDS. (b) Unlabeled 
fibronectin standard stained with Coomassie brilliant blue. 
The  biosynthetical ly labeled extracellular proteins of  C6 which bound 
collagen did not include detectable amounts  of a protein which was pres- 
ent in unlabeled fibronectin standards and was approximate ly  20,000 dal- 
tons smaller than the predominant  protein band (Figure 1 peak at 2). To 
test whether  this represented a true difference between gelatin binding 
proteins of  C6 and fibronectin f rom fibroblasts,  these two cell types were  
biosynthetical ly labeled in parallel and gelatin-agarose techniques for sep- 
arating fibroblast  f ibronectin were employed  on their extracellular pro- 
teins. The two electrophoret ic  profiles were similar in the absence  of  this 
smaller protein and in the presence  of a predominant  protein with the 
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FlG. 2. Autofluorograms and corresponding densitometric scans of biosynthetically labeled 
extracellular proteins eluted from gelatin-agarose beads with 10% SDS, reduced with 5% 2- 
ME and applied to a 5% polyacrylamide slab gel with 3% spacer gel. (a) Collagen binding 
proteins produced by C6 cellular cultures. (b) Collagen binding proteins produced by fi- 
broblast cultures. Arrows denote the interface between spacer and resolving gel. Repre- 
sentative data from 1 of 3 experiments. 
same migration in polyacrylamide (Figure 2 peaks at 1). By definition this 
large collagen binding protein derived from fibroblasts was fibronectin, 
conventionally reported to have a molecular weight of 220,000. Plots of 
log molecular weight versus migration of protein standards extrapolated 
to weights of 230,000 _+ 10,000 for the protein band at position 1. 
Among collagen binding proteins produced and released extracellutarly 
by C6 cells, the one at position 3 appeared to be distinct. It had a molecular 
weight of 270,000 _+ 15,000 extrapolated from plots of protein standards. 
This protein was larger than the fibroblast protein at position 4 as judged 
by its mobility in SDS polyacrylamide gels. 
The collagen binding proteins synthesized with [14C]leucine repre- 
sented 8% of all labeled proteins released by C6 and 34% of all labeled 
proteins released by fibroblasts into the medium during the 22 hr incu- 
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bation interval, as measured by precipitation with trichloroacetic acid. 
The extracellular collagen binding proteins represented 0.4 to 1% of all 
proteins synthesized by C6 and 1.5 to 3% of all proteins synthesized by 
fibroblasts. Of these collagen bound proteins, 60% were eluted by 8 M 
urea buffered at pH 7.2. At pH ! l, 8 M urea eluted 75% of bound protein. 
A 10% solution of SDS eluted 99% of bound protein. The presence of 
excess unlabeled fibronectin decreased the amount of collagen binding 
proteins which could be eluted with 8 M urea at pH 11 by 27% for C6 
proteins and by 54% for fibroblast controls. 
When the C6 glioma monolayer was exposed to 1 and to 2 M urea, the 
majority of extracted proteins were larger than 200,000 daltons. The major 
band removed by this method from monolayers of C6 co-electrophoresed 
with 220,000 dalton fibronectin extracted from fibroblast controls. Fol- 
lowing urea extractions, cells no longer adhered to the surface of the flask. 
Over 50% of cells were nonviable 30 min after extraction by analysis with 
Trypan blue. 
Immunofluorescent staining of C6 cells grown in the absence of exo- 
genous fibronectin showed weak surface and cytoplasmic and no nuclear 
staining. Absorption with fibronectin eliminated this staining. Only 5% 
of C6 cells showed surface fibrils, as compared with 99% of fibroblasts. 
DISCUSSION 
Two assays, neither requiring protein synthesis from labeled precur- 
sors, have generated different results pertaining to the production of fi- 
bronectin by C6 cells. Anti-fibronectin antibody plus ~25I labeled protein 
A localized 220,000 dalton molecules attached to dishes after removal of 
C6 cells (substrate attached material). These molecules had migrated in 
gels like cold-insoluble globulin (8). Cold-insoluble globulin is a fibro- 
nectin of serum and plasma similar but not identical to cellular fibronectin. 
While both molecules bind collagen and both are frequently reported to 
, be 220,000 daltons, cellular fibronectins are about 10,000 daltons larger 
than cold-insoluble globulins (29). Absorption and specificity controls sug- 
gested that rat glioma fibronectin rather than bovine serum fibronectin 
was identified by the anti-fibronectin (8). 
In a second assay cleansed of exogenous serum fibronectin, C6 cells 
were found not to express fibronectin as judged by indirect immunoflu- 
orescence with anti-fibronectin serum (9, 16). 
The present study identifies fibronectin as a product of the C6 rat glioma 
by multiple criteria. A discrete fraction of the proteins which are produced 
and released by C6 bound gelatin. Production of these proteins by C6 was 
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confirmed by biosynthesis from radiolabeled precursors and inhibition 
with cycloheximide. The most abundant of these gelatin binding proteins 
co-electrophoresed with a band in unlabeled fibronectin and with fibro- 
nectin biosynthesized by fibroblasts. Solubility in urea of this protein from 
C6 paralleled solubility of fibroblast fibronectin. Immunofluorescent 
staining showed less fibronectin associated with C6 cells than with fibro- 
blasts. Correlation of present and previous results suggest that C6 may 
make more fibronectin that it retains on its surface. Perhaps this reflects 
a scarcity of fibronectin receptors on C6 as compared to fibroblasts. 
An alternate hypothesis is that fibronectin might exert regulatory effects 
on its own production by C6 cells. Future work might investigate this 
possibility as well as the possibility that cell-surface or cell-cell interac- 
tions modulate the production of fibronectin by C6 cells. However, the 
task of the present study was to investigate the proteins from C6 to de- 
termine whether any of them have properties offibronectin. Two proteins 
were found, one with properties of fibronectin and one larger molecular 
weight protein which also binds collagen (glionectin). 
C6 cells are known to be among cells which produce molecules which 
attach to artificial substrates such as the surface of a culture dish (8, 30, 
31). Proteins and glycoproteins which adhere firmly to the dish can be 
separated from cells by removing the latter with EGTA (30). The sub- 
stances which remain on the dish are called substrate attached material 
(SAM). C6 ceils produce SAM which differs from SAM of fibroblasts in 
the greater amount of a 55,000 dalton protein made by C6 (31). More 
recently, electrophoretic similarities between larger molecules of SAM 
produced by C6 and serum-derived cold-insoluble globulin have been de- 
tected (8). The present study extends these important early observations 
by demonstrating the production of fibronectin by C6 as judged by the 
criteria of collagen binding, solubility and electrophoretic properties sim- 
ilar to fibronectin produced by fibroblasts. 
Minor differences between biosynthetically labeled and unlabeled fi- 
bronectin occurred. A portion of unlabeled fibronectin standard was about 
20,000 daltons smaller than the remainder and smaller than fibronectin 
synthesized by C6 cells and fibroblasts. The mobility offibronectin varies 
with exposure to enzymes (18). The band of slightly lower molecular 
weight in the unlabeled fibronectin standard may have been due to pro- 
teases or other modifying enzymes (18) differently active under conditions 
of preparatory extraction and purification as compared with in vitro short- 
term biosynthetic labeling. 
The observation that this prototype glioma cell line produces fibronectin 
lends credence to the proposal that cells cultured from a glioma and cloned 
for a CNS marker (S-100) can make fibronectin in vitro. Another glioma 
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line which may produce both a glial marker (GFAP) and fibronectin is U- 
251; however, U-251 lacks S-100 protein (1). In this regard it should be 
noted that the amount of fibronectin associated with U-251 in vitro is 
considerably less than the amount associated with certain other human 
glioma lines (1, 3, 32). 
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